MEDANTA — Global Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual income statement for Global Health, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	15,004	14,467	21,666	26,942	32,751
Cost of Revenue
Gross Profit	11,756	10,982	16,237	20,690	25,158
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	14,260	13,757	18,440	22,156	26,356
Operating Profit	744	711	3,226	4,787	6,395
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	639	325	2,806	4,493	6,271
Provision for Income Taxes
Net Income After Taxes	363	288	1,962	3,261	4,781
Minority Interest
Net Income Before Extraordinary Items
Net Income	363	288	1,962	3,261	4,782
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	363	288	1,962	3,261	4,782
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.36	1.06	7.25	12.6	17.8
Dividends per Share